Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea

Clinical Neurology and Neurosurgery

Volumn 110, Issue 2, 2008, Pages 160-167

  Fenney, Alison ^a   Jog, Mandar S ^b   Duval, Christian ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Chorea; Dyskinesia; Huntington; Involuntary movements; Motor topography; Parkinson

Indexed keywords

ADULT; AGED; AMPLITUDE; ARTICLE; BODY REGIONS; CHOREA; CLINICAL ARTICLE; CLINICAL OBSERVATION; DYSKINESIA; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; HUNTINGTON CHOREA; INVOLUNTARY MOVEMENT; LEVODOPA INDUCED DYSKINESIA; MAGNETIC MOTION TRACKER SYSTEM; MALE; MOTOR TOPOGRAPHY; PARAMETER; PARKINSON DISEASE; SHORT TERM VARIABILITY; SITTING; STANDING; STATISTICAL ANALYSIS; TIME; WHOLE BODY VIBRATION;

AGED; ANTIPARKINSON AGENTS; ARM; COHORT STUDIES; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; HUNTINGTON DISEASE; LEG; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; POSTURE; THORAX; TIME FACTORS;

EID: 38349133327     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.10.010     Document Type: Article

References (21)

1. Yahr M.D., Duvoisin R.C., Schear M.J., Barrett R.E., and Hoehn M.M. Treatment of parkinsonism-chronic treatment with levodopa. Arch Neurol 21 (1969) 343-354
2. Klawans H.L., Goetz C., and Bergen D. Levodopa-induced myoclonus. Arch Neurol 32 (1975) 300-334
3. de la Fuente-Fernandez R., Sossi V., Huang Z., Furtado S., Lu J.Q., Calne D.B., et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 127 Pt 12 (2004) 2747-2754
4. Marsden C.D., and Parkes J.D. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 1 (1977) 345-349
5. Rajput A.H., Fenton M.E., Birdi S., Macaulay R., George D., Rozdilsky B., et al. Clinical-pathological study of levodopa complications. Mov Disord 17 2 (2002) 289-296
6. Meunter M.D., Sharpless N.S., Tyce G.M., and Darley F.L. Patterns of dystonia ("I-D-I" and "D-I-D") in response to Levodopa therapy of Parkinson's disease. Mayo Clin Proc 52 (1977) 163-174
7. Melamed E. Early-morning dystonia: a late side effect of long-term levodopa therapy in Parkinson's disease. Arch Neurol 36 (1979) 308-310
8. Fahn S. The spectrum of Levodopa-induced LID. Ann Neurol 47 Suppl. 1 (2000) S2-S11
9. Berardelli A., Noth J., Thompson P.D., Bollen E.L.M., Curra A., Deuschl G., et al. Review: pathophysiology of chorea and bradykinesia in Huntington's disease. Mov Disord 14 3 (1999) 398-403
10. Bhidayasiri R., and Truong D.D. Chorea and related disorders. Postgrad Med J 80 (2004) 527-534
11. Yanagisawa N. The spectrum of motor disorders in Huntington's disease. Clin Neurol Neurosurg Suppl. S (1992) 182-184
12. Chapuis S., Ouchane L., Metz O., Gerbaud L., and Durif F. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord 20 2 (2005) 224-230
13. Helder D.I., Kaptein A.A., van Kempen G.M., van Houweligen J.C., and Roos R.A. Impact of Huntington's disease on quality of life. Mov Disord 16 2 (2001) 325-330
14. Ghassemi M., Lemieux S., Jog M., Edwards R., and Duval C. Bradykinesia in patients with Parkinson's disease having Levodopa-induced dyskinesias. Brain Res Bull 69 5 (2006) 512-518
15. Lemieux S., Ghassemi M., Jog M., Edwards R., and Duval C. The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease. Exp. Brain Res 176 3 (2007) 465-475
16. Fenney A., Jog M., and Duval C. Simultaneous quantification of whole-body chorea and voluntary movements in Huntington's disease (2006), Society for Neuroscience meeting held in Atlanta, GA
17. Djaldetti R., Ziv I., and Melamed E. The mystery of motor asymmetry in Parkinson's disease. Lancet Neurol 5 9 (2006) 796-802
18. Kumar N., Van Gerpen J.A., Bower J.H., and Ahlskog J.E. Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Mov Disorders 20 3 (2005) 342-344
19. Van Gerpen J.A., Kumar N., Bower J.H., Weigand S., and Ahlskog J.E. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. Arch Neurol 63 Feb, 2 (2006) 205-209
20. Dempster W.T., and Gaughran G.R.L. Properties of body segments based on size and weight. Am J Anatomy 120 1 (1967) 33
21. Horstink M.W., Zijlmans J.C., Pasman J.W., Berger H.J., and van't Hof M.A. Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia. J Neurol Neurosurg Psychiatry 53 March, 3 (1990) 224-226